Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy

Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy

Background and objective The presence of epidermal growth factor receptor (EGFR) mutations is predictive of a better response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) and initial chemotherapy in advanced non-squamous non-small cell lung cancer (NSCLC). The aim of this study is to analyze the a...

Full description

Bibliographic Details
Main Authors: Fuhai LI, Hua BAI, Xia’nan LI, Meina WU, Rong YU, Anhui SHI, Li YIN, Jie WANG, Guangying ZHU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Chemoradiotherapy
EGFR
Mutation
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2011.09.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2011.09.03

Similar Items